One of today's notable stocks on the rise is Medivation (NASDAQ:MDVN), up 2.4% to $112.62. The Dow Jones Industrial Average is now trading 0.3% lower to 18,089 and the S&P is trading 0.2% lower to 2,106.
In the past 52 weeks, shares of Medivation have traded between a low of $54.37 and a high of $117.23 and are now at $112.62, which is 107% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 1.0% while the 50-day MA has declined 0.5%.
Medivation has overhead space with shares priced $112.62, or 3.9% below the average consensus analyst price target of $117.17. The stock should discover initial support at its 50-day moving average (MA) of $104.69 and subsequent support at its 200-day MA of $92.03.
Medivation Inc. acquires, develops, and sells or partners biomedical technologies in the early development stage of the research and development process.